SC 13G

Company

Ernexa Therapeutics Inc.

Filed

March 18, 2020

Accession Number

0001477932-20-001392

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →